Cosmetics and personal care
Which rules apply to rinse-off skin cleansers?
We track 6,777 rules for these in 20 of 21 markets, including California's Prop 65 list of 883 chemicals. Check your product free, no account needed.
- Free
- No account needed
- The law behind every rule
Cosmetics and personal care / Skin care / Rinse-off skin cleansers
Face and body cleansers, scrubs and washes removed after application.
Rules
Rules by market
Open a market to read its rules for this category.
Main sources, from 18 May 2026 · What is covered
European Union: main sources stored. Modelled: Reg. 1223/2009 Annexes II (prohibited); III (restricted); IV (colourants); V (preservatives); VI (UV filters) and Art. 19 labelling; Arts. 4 to 13: Responsible Person, safety assessment and safety report (CPSR), product information file (PIF), CPNP notification. Not stored: CLP classification and labelling of cosmetic mixtures; REACH Annex XVII entries beyond cosmetics (e.g. microplastics Reg. 2023/2055); national rules (e.g. French recycling labels, German language rules); claims criteria (Reg. 655/2013); packaging law (PPWR); Annex III-VI entries adopted after the stored consolidation.
Art. 11 software-no-impediment
Banned
Consolidated text (not the authentic legal edition), current to 13 Aug 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02023R1542-20260813 from the Publications Office, the latest when read.
- Contains a battery
- Battery category: Portable battery or LMT battery (e-bike, e-scooter)
- Your role: Manufacturer or Importer
Depends on: contains battery, battery category, economic operator role
Takes effect 18 Feb 2027
Applies to products placed on the market on or after 18 Feb 2027
Article 11 applies from 18 February 2027 (Art. 96(2)(a)).
“Software shall not be used to impede the replacement of a portable battery or LMT battery, or of their key components, with another compatible battery or key components.”
1,588 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Banned
Show targets (40 of 1,588)
- Triphenyl Phosphate (CAS 115-86-6)
- 1-Chloro-4-nitrobenzene (CAS 100-00-5)
- 4-Vinylcyclohexene (CAS 100-40-3)
- Styrene (CAS 100-42-5)
- Benzyl chloride (CAS 100-44-7)
- Hymexazol (ISO); 3-hydroxy-5-methylisoxazole (CAS 10004-44-1)
- Nickel difluoride (CAS 10028-18-9)
- Strontium nitrate (CAS 10042-76-9)
- Boric acid (CAS 10043-35-3)
- Hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1) (CAS 10046-00-1)
- Distillates (petroleum), carbon-treated light paraffinic, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen (CAS 100683-97-4)
- Distillates (petroleum), intermediate paraffinic, carbon-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen (CAS 100683-98-5)
- Distillates (petroleum), intermediate paraffinic, clay-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen (CAS 100683-99-6)
- Extracts (petroleum), light paraffinic distillate solvent, carbon-treated, if they contain > 3 % w/w DMSO extract (CAS 100684-02-4)
- Extracts (petroleum), light paraffinic distillate solvent, clay-treated, if they contain > 3 % w/w DMSO extract (CAS 100684-03-5)
- Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated, if they contain > 3 % w/w DMSO extract (CAS 100684-04-6)
- Extracts (petroleum), light vacuum gas oil solvent, clay-treated, if they contain > 3 % w/w DMSO extract (CAS 100684-05-7)
- Petrolatum (petroleum), clay-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen (CAS 100684-33-1)
- Residual oils (petroleum), carbon-treated solvent-dewaxed, if they contain > 3 % w/w DMSO extract (CAS 100684-37-5)
- Residual oils (petroleum), clay-treated solvent-dewaxed, if they contain > 3 % w/w DMSO extract (CAS 100684-38-6)
- Slack wax (petroleum), carbon-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen (CAS 100684-49-9)
- halosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6- dimethoxypyrimidin-2-yl) carbamoyl]sulfamoyl}-1- methyl-1H-pyrazole-4- carboxylate (CAS 100784-20-1)
- Fenadiazole (INN) (CAS 1008-65-7)
- (6R-trans)-1-((7-Ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide (CAS 100988-63-4)
- Chlorpropham (ISO); isopropyl 3-chlorocarbanilate (CAS 101-21-3)
- Hyoscyamine, its salts and derivatives (CAS 101-31-5)
- 4,4'-Methylene bis(N,N-dimethyl)benzenamine (CAS 101-61-1)
- 4,4′-Methylenediphenyl diisocyanate; diphenylmethane-4,4′-diisocyanate (CAS 101-68-8)
- 4,4'-Methylenedianiline (CAS 101-77-9)
- 4,4'-Diaminodiphenyl ether (4,4'-Oxydianiline) (CAS 101-80-4)
- Diglycidyl resorcinol ether (DGRE) (CAS 101-90-6)
- Nickel(II) selenite (CAS 10101-96-9)
- Cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one (CAS 101205-02-1)
- Cobalt sulfate (CAS 10124-43-3)
- Absorption oils, bicyclo arom. and heterocylic hydrocarbon fraction, if they contain > 0,005 % w/w benzo[a]pyrene (CAS 101316-45-4)
- Distillates (petroleum), hydrodesulfurised full-range middle (CAS 101316-57-8)
- Distillates (petroleum), hydrodesulfurised middle coker (CAS 101316-59-0)
- Lubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated, if they contain > 3 % w/w DMSO extract (CAS 101316-69-2)
- Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated, if they contain > 3 % w/w DMSO extract (CAS 101316-70-5)
- Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated, if they contain > 3 % w/w DMSO extract (CAS 101316-71-6)
The remaining targets are listed on the substances page.
Every product in the category
Dates run from 1 Dec 2010 to 1 Jan 2027
Each rule has its own date; open a target.
Example: Triphenyl Phosphate (CAS 115-86-6)
From the consolidated text: Triphenyl Phosphate (13) · 115-86-6 · 204-112-2
Annex II entry 1767 · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Limit 0.7 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (f) 0,7 %. Field of application: (f) Body lotion.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Body
Depends on: body area
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
From the consolidated text: (f) Body lotion · (f) 0,7 %
Annex III entry 75 (l5) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)174 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.2 % (content basis)
Show targets (40 of 174)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) (Benzoic acid, 2-[4-(diethylamino)-2- hydroxybenzoyl]-, hexyl ester; CAS 302776-68-7)
- Citral Geranial (CAS 5392-40-5)
- Citral Geranial (CAS 5392-40-5)
- Zinc Acetate (CAS 557-34-6)
- Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Benzyl Alcohol (CAS 100-51-6)
- Hexamethylenetetramine (CAS 100-97-0)
- Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (CAS 103597-45-1)
- Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (CAS 103597-45-1)
- Chlorphenesin (3-(p-Chlorophenoxy)-propane-1,2 diol; CAS 104-29-0)
- Hydroxycitronellal (7-Hydroxycitronellal; CAS 107-75-5)
- Sorbic acid, calcium sorbate, sodium sorbate, potassium sorbate (Hexa-2,4-dienoic acid and its salts; CAS 110-44-1)
- Methyl 2-Octynoate (Methyl Oct-2-ynoate; CAS 111-12-6)
- Methyl 2-Octynoate (Methyl Oct-2-ynoate; CAS 111-12-6)
- Glutaral (Glutaraldehyde (Pentane-1,5-dial); CAS 111-30-8)
- Diethylene glycol (Diethylene glycol (DEG); CAS 111-46-6)
- Methyl octine carbonate (Methyl octine carbonate; CAS 111-80-8)
- Methyl octine carbonate (Methyl octine carbonate; CAS 111-80-8)
- Retinol (CAS 11103-57-4)
- Undecylenic acid, potassium undecylenate, sodium undecylenate, calcium undecylenate (Undec-10-enoic acid and its salts; CAS 112-38-9)
- Polyacrylamidomethyl Benzylidene Camphor (CAS 113783-61-2)
- PEG-25 PABA (Ethoxylated ethyl-4-aminobenzoate; CAS 116242-27-4)
- Ethylhexyl Salicylate (2-Ethylhexyl salicylate/Octisalate; CAS 118-60-5)
- Methyl Salicylate (Methyl 2-hydroxybenzoate; CAS 119-36-8)
- Methyl Salicylate (Methyl 2-hydroxybenzoate; CAS 119-36-8)
- Methyl Salicylate (Methyl 2-hydroxybenzoate; CAS 119-36-8)
- Phenoxyethanol (2-Phenoxyethanol; CAS 122-99-6)
- Allyl Caproate (Allyl hexanoate; CAS 123-68-2)
- Chloramine-T (Tosylchloramide sodium (INN); CAS 127-65-1)
- BHT (2,6-Di-tert-butyl-p-cresol; CAS 128-37-0)
- Ammonium Silver Zinc Aluminium Silicate (CAS 130328-20-0)
- Benzophenone-3 (2-Hydroxy-4-methoxy-benzophenone/Oxybenzone; CAS 131-57-7)
- Potassium hydroxide (Potassium or sodium hydroxide; CAS 1310-58-3)
- CI 77947 (Zinc oxide; CAS 1314-13-2)
The remaining targets are listed on the substances page.
Every product in the category
Dates run from 11 Jul 2013 to 1 Jan 2027
Each rule has its own date; open a target.
Example: Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
From the consolidated text: (g) Face make-up and make-up remover products · (g) 0,2 %
Annex III entry 75 (l6) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)37 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.004 % (content basis)
Show targets (37 of 37)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Citral Geranial (CAS 5392-40-5)
- Sodium Monofluorophosphate (Disodium fluorophosphate; CAS 10163-15-2)
- Strontium chloride (Strontium chloride hexahydrate; CAS 10476-85-4)
- Ammonium Fluoride (CAS 12125-01-8)
- Potassium Monofluorophosphate (Dipotassium fluorophosphate; CAS 14104-28-0)
- Potassium Fluorosilicate (Dipotassium hexafluorosilicate; CAS 16871-90-2)
- Sodium Fluorosilicate (Disodium hexafluorosilicate; CAS 16893-85-9)
- Ammonium Fluorosilicate (Ammonium hexafluorosilicate; CAS 16919-19-0)
- Magnesium Fluorosilicate (Magnesium hexafluorosilicate; CAS 16949-65-8)
- Ammonium Monofluorophosphate (CAS 20859-38-5)
- Acetyl hexamethyl tetralin (CAS 21145-77-7)
- Acetyl hexamethyl tetralin (CAS 21145-77-7)
- Acetyl hexamethyl tetralin (CAS 21145-77-7)
- Acetyl hexamethyl tetralin (CAS 21145-77-7)
- Acetyl hexamethyl tetralin (CAS 21145-77-7)
- Cetylamine Hydrofluoride (Hexadecyl ammonium fluoride; CAS 3151-59-5)
- Octadecenyl-Ammonium Fluoride (9-Octadecen-1-amine hydrofluoride; CAS 36505-83-6)
- Strontium acetate (Strontium acetate hemihydrate; CAS 543-94-2)
- Nicomethanol Hydrofluoride (3-Pyridinemethanol hydrofluoride; CAS 62756-44-9)
- Benzoic acid Sodium Benzoate (Benzoic acid and its sodium salt; CAS 65-85-0)
- Sodium Fluoride (CAS 7681-49-4)
- Magnesium Fluoride (CAS 7783-40-6)
- Stannous Fluoride (Tin difluoride; CAS 7783-47-3)
- Aluminum Fluoride (Aluminium fluoride; CAS 7784-18-1)
- Potassium Fluoride (CAS 7789-23-3)
- Calcium Monofluorophosphate (Calcium fluorophosphate; CAS 7789-74-4)
- Calcium Fluoride (CAS 7789-75-5)
- Musk ketone (4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone; CAS 81-14-1)
- Musk ketone (4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone; CAS 81-14-1)
- Musk ketone (4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone; CAS 81-14-1)
- Musk xylene (5-tert-Butyl-2,4,6-trinitro-m-xylene; CAS 81-15-2)
- Musk xylene (5-tert-Butyl-2,4,6-trinitro-m-xylene; CAS 81-15-2)
- Musk xylene (5-tert-Butyl-2,4,6-trinitro-m-xylene; CAS 81-15-2)
- 6-Methyl Coumarin (6-Methylcoumarin; CAS 92-48-8)
- 3-(N-Hexadecyl-N-2-hydroxyethylammonio)propylbis(2-hydroxyethyl) ammonium difluoride
- N,N′,N′-Tris(polyoxyethylene)-N-hexadecylpropylenediamine dihydrofluoride
- Applied to: Mouth or Teeth and gums
Depends on: body area
Dates run from 11 Jul 2013 to 1 Jan 2027
Each rule has its own date; open a target.
Example: Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
From the consolidated text: (h) Oral products · (h) 0,004 %
Annex III entry 75 (l7) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Limit 0.65 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (c) 0,65 %. Field of application: (c) Eye products, face make-up and make-up remover.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Eye area
Depends on: body area
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-08-01. The row-level date is read from the annex footnote (EU).
From the consolidated text: (c) Eye products, face make-up and make-up remover · (c) 0,65 %
Annex III entry 70 (l2) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)14 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.063 % (content basis)
Show targets (14 of 14)
- Citral Geranial (CAS 5392-40-5)
- Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Acetyl Hexamethyl indan (1,1,2,3,3,6-Hexamethylindan-5-yl methyl ketone; CAS 15323-35-0)
- Laureth-9 (Polidocanol; CAS 3055-99-0)
- Iodopropynyl butylcarbamate (3-Iodo-2-propynylbutylcarbamate; CAS 55406-53-6)
- Benzoic acid Sodium Benzoate (Benzoic acid and its sodium salt; CAS 65-85-0)
- Cuminum Cyminum Fruit Oil (Cuminum cyminum oil and extract; CAS 84775-51-9)
- Methyl-N-methylanthranilate (CAS 85-91-6)
- o-Phenylphenol (CAS 90-43-7)
- Tagetes patula flower extract Tagetes patula flower oil (CAS 91722-29-1)
- Tagetes minuta flower extract Tagetes minuta flower oil (CAS 91770-75-1)
- Trialkylamines, trialkanolamines and their salts
- Leave-on product
Depends on: rinse off
Dates run from 11 Jul 2013 to 1 Jan 2027
Each rule has its own date; open a target.
Example: Citral Geranial (CAS 5392-40-5)
From the consolidated text: (i) Leave-on products for the anogenital area (baby wipes and intimate wipes) · (i) 0,063 %
Annex III entry 70 (l8) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)17 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.2 % (content basis)
Show targets (17 of 17)
- Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Triclocarban (CAS 101-20-2)
- Benzylhemiformal (Methanol, (phenylmethoxy-); CAS 14548-60-8)
- Methylchloroisothiazolinone (and) Methylisothiazolinone (CAS 26172-55-4)
- Methylisothiazolinone (2-Methyl-2H-isothiazol-3-one; CAS 2682-20-4)
- 5-Bromo-5-nitro-1,3-dioxane (CAS 30007-47-7)
- Laureth-9 (Polidocanol; CAS 3055-99-0)
- 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl) 2-pyridon (CAS 50650-76-5)
- Iodopropynyl butylcarbamate (3-Iodo-2-propynylbutylcarbamate; CAS 55406-53-6)
- Phenoxyisopropanol (1-Phenoxypropan-2-ol; CAS 770-35-4)
- Methyl-N-methylanthranilate (CAS 85-91-6)
- o-Phenylphenol (CAS 90-43-7)
- Tagetes patula flower extract Tagetes patula flower oil (CAS 91722-29-1)
- Tagetes minuta flower extract Tagetes minuta flower oil (CAS 91770-75-1)
- Methyleugenol (CAS 93-15-2)
- CI 42520
- Rinse-off product
Depends on: rinse off
Dates run from 11 Jul 2013 to 1 Jan 2027
Each rule has its own date; open a target.
Example: Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
“(a) 0,9 % (b) 0,05 % (c) 0,05 % (d) 0,1 % (e) 0,2 %”
Limit 14.62 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (d) 14,62 % (as Al). Field of application: (d) Lip products.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Lips
Depends on: body area
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
From the consolidated text: (d) Lip products · (d) 14,62 % (as Al)
Annex III entry 381 (l3) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Art. 11 removable-replaceable-lmt
Must meet the conditions of LMT batteries and their cells are readily removable and replaceable by an independent professional at any time during the product's lifetime
Consolidated text (not the authentic legal edition), current to 13 Aug 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02023R1542-20260813 from the Publications Office, the latest when read.
- Your role: Manufacturer or Importer
- Contains a battery
- Battery category: LMT battery (e-bike, e-scooter)
Depends on: economic operator role, contains battery, battery category
Takes effect 18 Feb 2027
Applies to products placed on the market on or after 18 Feb 2027
Article 11 applies from 18 February 2027 (Art. 96(2)(a)).
“shall ensure that those batteries, as well as individual battery cells included in the battery pack, are readily removable and replaceable by an independent professional”
Art. 11 removable-replaceable-portable
Must meet the conditions of Portable batteries incorporated in the product are readily removable and replaceable by the end-user at any time during the product's lifetime (commercially available tools; entire batteries, not cells)
Exemptions (3)
Art. 11(2)(a): appliances designed for splashing water, water streams or immersion and intended to be washable or rinseable may make the battery removable by independent professionals only, where required for safety
“appliances specifically designed to operate primarily in an environment that is regularly subject to splashing water, water streams or water immersion, and that are intended to be washable or rinseable;”
Art. 11(2)(b): professional medical imaging and radiotherapy devices and in vitro diagnostic devices
“professional medical imaging and radiotherapy devices, as defined in Article 2, point (1), of Regulation (EU) 2017/745,”
Art. 11(3): no duty where continuity of power supply is necessary and a permanent connection is required for safety, or for data integrity in data-collecting products
“The obligations laid down in paragraph 1 shall not apply where continuity of power supply is necessary”
Consolidated text (not the authentic legal edition), current to 13 Aug 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02023R1542-20260813 from the Publications Office, the latest when read.
- Contains a battery
- Battery category: Portable battery
- Your role: Manufacturer or Importer
Depends on: contains battery, battery category, economic operator role
Takes effect 18 Feb 2027
Applies to products placed on the market on or after 18 Feb 2027
Article 11 applies from 18 February 2027 (Art. 96(2)(a)).
“products incorporating portable batteries shall ensure that those batteries are readily removable and replaceable by the end-user at any time during the lifetime of the product.”
Art. 11 removal-instructions
Disclosure to consumer
Instructions and safety information on use, removal and replacement of the portable battery, permanently available online
Exemptions (3)
Art. 11(2)(a): appliances designed for splashing water, water streams or immersion and intended to be washable or rinseable may make the battery removable by independent professionals only, where required for safety
“appliances specifically designed to operate primarily in an environment that is regularly subject to splashing water, water streams or water immersion, and that are intended to be washable or rinseable;”
Art. 11(2)(b): professional medical imaging and radiotherapy devices and in vitro diagnostic devices
“professional medical imaging and radiotherapy devices, as defined in Article 2, point (1), of Regulation (EU) 2017/745,”
Art. 11(3): no duty where continuity of power supply is necessary and a permanent connection is required for safety, or for data integrity in data-collecting products
“The obligations laid down in paragraph 1 shall not apply where continuity of power supply is necessary”
Consolidated text (not the authentic legal edition), current to 13 Aug 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02023R1542-20260813 from the Publications Office, the latest when read.
- Contains a battery
- Battery category: Portable battery
- Your role: Manufacturer or Importer
Depends on: contains battery, battery category, economic operator role
Takes effect 18 Feb 2027
Applies to products placed on the market on or after 18 Feb 2027
Article 11 applies from 18 February 2027 (Art. 96(2)(a)).
“Those instructions and that safety information shall be made available permanently online, on a publicly available website, in an easily understandable way for end-users.”
Art. 11 spare-part-availability
Must meet the conditions of Batteries available as spare parts for at least five years after the last unit of the model is placed on the market, at a reasonable and non-discriminatory price
Consolidated text (not the authentic legal edition), current to 13 Aug 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02023R1542-20260813 from the Publications Office, the latest when read.
- Contains a battery
- Battery category: Portable battery or LMT battery (e-bike, e-scooter)
- Your role: Manufacturer or Importer
Depends on: contains battery, battery category, economic operator role
Takes effect 18 Feb 2027
Applies to products placed on the market on or after 18 Feb 2027
Article 11 applies from 18 February 2027 (Art. 96(2)(a)).
“those batteries are available as spare parts of the equipment that they power for a minimum of five years after placing the last unit of the equipment model on the market”
Placing on the market of a cosmetic whose final formulation was animal tested
Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Tested on animals
Depends on: animal testing conducted
In force since 11 Mar 2013
Applies to products placed on the market on or after 11 Mar 2013
Art. 18(2): the implementation period for Art. 18(1)(a) was limited to 11 March 2009, and to 11 March 2013 for repeated-dose toxicity, reproductive toxicity and toxicokinetics tests, so the marketing ban covers all tests from 2013-03-11. Art. 40(2) applies the Regulation from 2013-07-11 and does not list Art. 18 among its exceptions.
“the placing on the market of cosmetic products where the final formulation, in order to meet the requirements of this Regulation, has been the subject of animal testing”
Placing on the market of a cosmetic with animal-tested ingredients or combinations of ingredients
Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Tested on animals
Depends on: animal testing conducted
In force since 11 Mar 2013
Applies to products placed on the market on or after 11 Mar 2013
Art. 18(2): the implementation period for Art. 18(1)(b) was limited to 11 March 2009, and to 11 March 2013 for repeated-dose toxicity, reproductive toxicity and toxicokinetics tests, so the marketing ban covers all tests from 2013-03-11. Art. 40(2) applies the Regulation from 2013-07-11 and does not list Art. 18 among its exceptions.
“the placing on the market of cosmetic products containing ingredients or combinations of ingredients which, in order to meet the requirements of this Regulation, have been the subject of animal testing”
19 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Banned
Show targets (19 of 19)
- Acid red 195 (CAS 12220-24-5)
- CI 15800 (Calcium bis[3-hydroxy-4-(phenylazo)-2-naphthoate])
- CI 10020
- CI 16230 (Disodium 7-hydroxy-8-(phenylazo)naphthalene-1,3-disulphonate)
- CI 18050
- CI 21230
- CI 11680 (2-[(4-Methyl-2-nitrophenyl)azo]-3-oxo-N-phenylbutyramide)
- CI 26100
- CI 42045
- CI 11710
- CI 42510
- CI 42735
- CI 44045
- CI 47000
- CI 50420 (Sulfonated nigrosine color)
- CI 59040 (Trisodium 8-hydroxypyrene-1,3,6-trisulphonate)
- CI 12010 (4-[(4-Ethoxyphenyl)azo]naphthol)
- CI 60730
- CI 71105 (Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione)
- Applied to: Lips or Mouth or Teeth and gums or External genital area
Depends on: body area
11 Jul 2013
Each rule has its own date; open a target.
Example: Acid red 195 (CAS 12220-24-5)
From the consolidated text: Sodium 4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonate · Acid red 195 · 12220-24-5 · — · Red · Not to be used in products applied on mucous membranes
Annex IV entry 153 (restriction) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Banned
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Mouth or Teeth and gums
Depends on: body area
In force, start date unknown
No date for this row is stated in the published text (consolidation marker M36; the amending act's application date is not printed). In force no later than 2026-05-18 (the date of the version ClaraDB holds); earlier commencement is not stated in the published text.
“Not to be used in oral products.”
32 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Banned
Show targets (32 of 32)
- Bromothymol blue (CAS 76-59-5)
- Bromocresol green (CAS 76-60-8)
- CI 73900 (5,12-Dihydroquino[2,3-b]acridine-7,14-dione)
- CI 73915 (5,12-Dihydro-2,9-dimethylquino[2,3-b]acridine-7,14-dione)
- CI 74100 (29H,31H-Phthalocyanine)
- CI 74180
- CI 12120 (1-[(4-Methyl-2-nitrophenyl)azo]-2-naphthol)
- CI 12370
- CI 12420
- CI 12480
- CI 12700 (2,4-Dihydro-5-methyl-2-phenyl-4-(phenylazo)-3H-pyrazol-3-one)
- CI 10006
- CI 15620 (Sodium 4-[(2-Hydroxy-1-naphthyl)azo]naphthalenesulphonate)
- CI 18130
- CI 18690
- CI 18736
- CI 18820
- CI 20470
- CI 24790
- CI 40215
- CI 42080
- CI 42100
- CI 42170
- CI 11725
- CI 45100
- CI 45190
- CI 45220
- CI 50325
- CI 51319
- CI 60724 (1-Anilino-4-hydroxyanthraquinone)
- CI 61585
- CI 62045
- Leave-on product
Depends on: rinse off
11 Jul 2013
Each rule has its own date; open a target.
Example: Bromothymol blue (CAS 76-59-5)
From the consolidated text: Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2-bromo-3-methyl-6-(1-methylethyl)-, S,S-dioxide · Bromothymol blue · 76-59-5 · 200-971-2 · Blue · Rinse-off products
Annex IV entry 151 (leave-on) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Eye area
Depends on: body area
In force since 11 Jul 2013
Applies to products placed on the market on or after 11 Jul 2013
No row-level date in the consolidated text for this entry; it applies from the Regulation's application date (Art. 40: 11 July 2013). Later amendments (the ▼M markers) are not dated row by row in the text.
From the consolidated text: Polychloro copper phthalocyanine · 74260 · Green · Not to be used in eye products
Annex IV entry 107 (restriction) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Eye area
Depends on: body area
In force since 11 Jul 2013
Applies to products placed on the market on or after 11 Jul 2013
No row-level date in the consolidated text for this entry; it applies from the Regulation's application date (Art. 40: 11 July 2013). Later amendments (the ▼M markers) are not dated row by row in the text.
From the consolidated text: Sodium 4-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments · 15510 · Orange · Not to be used in eye products
Annex IV entry 21 (restriction) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Eye area
Depends on: body area
In force since 11 Jul 2013
Applies to products placed on the market on or after 11 Jul 2013
No row-level date in the consolidated text for this entry; it applies from the Regulation's application date (Art. 40: 11 July 2013). Later amendments (the ▼M markers) are not dated row by row in the text.
From the consolidated text: Disodium 5,7-dinitro-8-oxidonaphthalene-2-sulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments · 10316 · Yellow · Not to be used in eye products
Annex IV entry 3 (restriction) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Eye area
Depends on: body area
In force since 11 Jul 2013
Applies to products placed on the market on or after 11 Jul 2013
No row-level date in the consolidated text for this entry; it applies from the Regulation's application date (Art. 40: 11 July 2013). Later amendments (the ▼M markers) are not dated row by row in the text.
From the consolidated text: Dipotassium 3,6-dichloro-2-(2,4,5,7-tetrabromo-6-oxido-3-oxoxanthen-9-yl)benzoate · 45405 · Red · Not to be used in eye products
Annex IV entry 78 (restriction) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Limit 0.05 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE. Field of application: (a) Body lotion (b) other leave-on and rinse-off products. Other: For any cosmetic product containing Retinol, Retinyl Acetate or Retinyl Palmitate the following, labelling is obligatory: ‘Contains Vitamin A. Consider your daily intake before use’..
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Body
Depends on: body area
In force since 1 Nov 2025
Applies to products placed on the market on or after 1 Nov 2025
Row footnote: products containing the substance shall not be placed on the Union market from 2025-11-01 and not be made available from 2027-05-01. The row-level date is read from the annex footnote (EU).
From the consolidated text: 234-328-2/ 200-683-7 · (a) Body lotion (b) other leave-on and rinse-off products · (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE
Annex III entry 376 (v1a) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Limit 0.5 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (a) 2 % (b) 0,5 %. Field of application: (a) Face cream (b) Body lotion. Other: Hydroquinone levels shall remain as low as possible in formulations containing alpha-Arbutin and shall not be higher than the unavoidable trace level..
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Body
Depends on: body area
In force since 1 Feb 2025
Applies to products placed on the market on or after 1 Feb 2025
Row footnote: products containing the substance shall not be placed on the Union market from 2025-02-01 and not be made available from 2025-11-01. The row-level date is read from the annex footnote (EU).
From the consolidated text: 4-Hydroxyphenyl-alpha-D-glucopyranoside (44) · Alpha-Arbutin · 84380-01-8 · 617-561-8 · (a) Face cream (b) Body lotion · (a) 2 % (b) 0,5 %
Annex III entry 377 (v2b) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Limit 0.007 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: 0,007 % (of Hg) If mixed with other mercurial compounds authorised by this Regulation, the maximum concentration of Hg remains fixed at 0,007 %. Field of application: Eye products.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Eye area
Depends on: body area
In force since 11 Jul 2013
Applies to products placed on the market on or after 11 Jul 2013
No row-level date in the consolidated text for this entry; it applies from the Regulation's application date (Art. 40: 11 July 2013). Later amendments (the ▼M markers) are not dated row by row in the text.
“0,007 % (of Hg) If mixed with other mercurial compounds authorised by this Regulation, the maximum concentration of Hg remains fixed at 0,007 %”
- Ban
Art. 11 software-no-impediment
Banned
Consolidated text (not the authentic legal edition), current to 13 Aug 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02023R1542-20260813 from the Publications Office, the latest when read.
- Applies when
- Contains a battery
- Battery category: Portable battery or LMT battery (e-bike, e-scooter)
- Your role: Manufacturer or Importer
Depends on: contains battery, battery category, economic operator role
- Effective
Takes effect 18 Feb 2027
Applies to products placed on the market on or after 18 Feb 2027
Article 11 applies from 18 February 2027 (Art. 96(2)(a)).
- Source
“Software shall not be used to impede the replacement of a portable battery or LMT battery, or of their key components, with another compatible battery or key components.”
Art. 11(8) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EU) 2023/1542(opens in a new tab)
- Ban x 1,588
1,588 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Banned
Show targets (40 of 1,588)
- Triphenyl Phosphate (CAS 115-86-6)
- 1-Chloro-4-nitrobenzene (CAS 100-00-5)
- 4-Vinylcyclohexene (CAS 100-40-3)
- Styrene (CAS 100-42-5)
- Benzyl chloride (CAS 100-44-7)
- Hymexazol (ISO); 3-hydroxy-5-methylisoxazole (CAS 10004-44-1)
- Nickel difluoride (CAS 10028-18-9)
- Strontium nitrate (CAS 10042-76-9)
- Boric acid (CAS 10043-35-3)
- Hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1) (CAS 10046-00-1)
- Distillates (petroleum), carbon-treated light paraffinic, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen (CAS 100683-97-4)
- Distillates (petroleum), intermediate paraffinic, carbon-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen (CAS 100683-98-5)
- Distillates (petroleum), intermediate paraffinic, clay-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen (CAS 100683-99-6)
- Extracts (petroleum), light paraffinic distillate solvent, carbon-treated, if they contain > 3 % w/w DMSO extract (CAS 100684-02-4)
- Extracts (petroleum), light paraffinic distillate solvent, clay-treated, if they contain > 3 % w/w DMSO extract (CAS 100684-03-5)
- Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated, if they contain > 3 % w/w DMSO extract (CAS 100684-04-6)
- Extracts (petroleum), light vacuum gas oil solvent, clay-treated, if they contain > 3 % w/w DMSO extract (CAS 100684-05-7)
- Petrolatum (petroleum), clay-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen (CAS 100684-33-1)
- Residual oils (petroleum), carbon-treated solvent-dewaxed, if they contain > 3 % w/w DMSO extract (CAS 100684-37-5)
- Residual oils (petroleum), clay-treated solvent-dewaxed, if they contain > 3 % w/w DMSO extract (CAS 100684-38-6)
- Slack wax (petroleum), carbon-treated, except if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen (CAS 100684-49-9)
- halosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6- dimethoxypyrimidin-2-yl) carbamoyl]sulfamoyl}-1- methyl-1H-pyrazole-4- carboxylate (CAS 100784-20-1)
- Fenadiazole (INN) (CAS 1008-65-7)
- (6R-trans)-1-((7-Ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide (CAS 100988-63-4)
- Chlorpropham (ISO); isopropyl 3-chlorocarbanilate (CAS 101-21-3)
- Hyoscyamine, its salts and derivatives (CAS 101-31-5)
- 4,4'-Methylene bis(N,N-dimethyl)benzenamine (CAS 101-61-1)
- 4,4′-Methylenediphenyl diisocyanate; diphenylmethane-4,4′-diisocyanate (CAS 101-68-8)
- 4,4'-Methylenedianiline (CAS 101-77-9)
- 4,4'-Diaminodiphenyl ether (4,4'-Oxydianiline) (CAS 101-80-4)
- Diglycidyl resorcinol ether (DGRE) (CAS 101-90-6)
- Nickel(II) selenite (CAS 10101-96-9)
- Cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one (CAS 101205-02-1)
- Cobalt sulfate (CAS 10124-43-3)
- Absorption oils, bicyclo arom. and heterocylic hydrocarbon fraction, if they contain > 0,005 % w/w benzo[a]pyrene (CAS 101316-45-4)
- Distillates (petroleum), hydrodesulfurised full-range middle (CAS 101316-57-8)
- Distillates (petroleum), hydrodesulfurised middle coker (CAS 101316-59-0)
- Lubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated, if they contain > 3 % w/w DMSO extract (CAS 101316-69-2)
- Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated, if they contain > 3 % w/w DMSO extract (CAS 101316-70-5)
- Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated, if they contain > 3 % w/w DMSO extract (CAS 101316-71-6)
The remaining targets are listed on the substances page.
- Applies when
Every product in the category
- Effective
Dates run from 1 Dec 2010 to 1 Jan 2027
Each rule has its own date; open a target.
- Source
Example: Triphenyl Phosphate (CAS 115-86-6)
From the consolidated text: Triphenyl Phosphate (13) · 115-86-6 · 204-112-2
Annex II entry 1767 · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- LimitBenzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
Limit 0.7 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (f) 0,7 %. Field of application: (f) Body lotion.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Body
Depends on: body area
- Effective
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
- Source
From the consolidated text: (f) Body lotion · (f) 0,7 %
Annex III entry 75 (l5) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- Limit x 174
174 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.2 % (content basis)
Show targets (40 of 174)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) (Benzoic acid, 2-[4-(diethylamino)-2- hydroxybenzoyl]-, hexyl ester; CAS 302776-68-7)
- Citral Geranial (CAS 5392-40-5)
- Citral Geranial (CAS 5392-40-5)
- Zinc Acetate (CAS 557-34-6)
- Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Benzyl Alcohol (CAS 100-51-6)
- Hexamethylenetetramine (CAS 100-97-0)
- Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (CAS 103597-45-1)
- Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (CAS 103597-45-1)
- Chlorphenesin (3-(p-Chlorophenoxy)-propane-1,2 diol; CAS 104-29-0)
- Hydroxycitronellal (7-Hydroxycitronellal; CAS 107-75-5)
- Sorbic acid, calcium sorbate, sodium sorbate, potassium sorbate (Hexa-2,4-dienoic acid and its salts; CAS 110-44-1)
- Methyl 2-Octynoate (Methyl Oct-2-ynoate; CAS 111-12-6)
- Methyl 2-Octynoate (Methyl Oct-2-ynoate; CAS 111-12-6)
- Glutaral (Glutaraldehyde (Pentane-1,5-dial); CAS 111-30-8)
- Diethylene glycol (Diethylene glycol (DEG); CAS 111-46-6)
- Methyl octine carbonate (Methyl octine carbonate; CAS 111-80-8)
- Methyl octine carbonate (Methyl octine carbonate; CAS 111-80-8)
- Retinol (CAS 11103-57-4)
- Undecylenic acid, potassium undecylenate, sodium undecylenate, calcium undecylenate (Undec-10-enoic acid and its salts; CAS 112-38-9)
- Polyacrylamidomethyl Benzylidene Camphor (CAS 113783-61-2)
- PEG-25 PABA (Ethoxylated ethyl-4-aminobenzoate; CAS 116242-27-4)
- Ethylhexyl Salicylate (2-Ethylhexyl salicylate/Octisalate; CAS 118-60-5)
- Methyl Salicylate (Methyl 2-hydroxybenzoate; CAS 119-36-8)
- Methyl Salicylate (Methyl 2-hydroxybenzoate; CAS 119-36-8)
- Methyl Salicylate (Methyl 2-hydroxybenzoate; CAS 119-36-8)
- Phenoxyethanol (2-Phenoxyethanol; CAS 122-99-6)
- Allyl Caproate (Allyl hexanoate; CAS 123-68-2)
- Chloramine-T (Tosylchloramide sodium (INN); CAS 127-65-1)
- BHT (2,6-Di-tert-butyl-p-cresol; CAS 128-37-0)
- Ammonium Silver Zinc Aluminium Silicate (CAS 130328-20-0)
- Benzophenone-3 (2-Hydroxy-4-methoxy-benzophenone/Oxybenzone; CAS 131-57-7)
- Potassium hydroxide (Potassium or sodium hydroxide; CAS 1310-58-3)
- CI 77947 (Zinc oxide; CAS 1314-13-2)
The remaining targets are listed on the substances page.
- Applies when
Every product in the category
- Effective
Dates run from 11 Jul 2013 to 1 Jan 2027
Each rule has its own date; open a target.
- Source
Example: Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
From the consolidated text: (g) Face make-up and make-up remover products · (g) 0,2 %
Annex III entry 75 (l6) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- Limit x 37
37 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.004 % (content basis)
Show targets (37 of 37)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Citral Geranial (CAS 5392-40-5)
- Sodium Monofluorophosphate (Disodium fluorophosphate; CAS 10163-15-2)
- Strontium chloride (Strontium chloride hexahydrate; CAS 10476-85-4)
- Ammonium Fluoride (CAS 12125-01-8)
- Potassium Monofluorophosphate (Dipotassium fluorophosphate; CAS 14104-28-0)
- Potassium Fluorosilicate (Dipotassium hexafluorosilicate; CAS 16871-90-2)
- Sodium Fluorosilicate (Disodium hexafluorosilicate; CAS 16893-85-9)
- Ammonium Fluorosilicate (Ammonium hexafluorosilicate; CAS 16919-19-0)
- Magnesium Fluorosilicate (Magnesium hexafluorosilicate; CAS 16949-65-8)
- Ammonium Monofluorophosphate (CAS 20859-38-5)
- Acetyl hexamethyl tetralin (CAS 21145-77-7)
- Acetyl hexamethyl tetralin (CAS 21145-77-7)
- Acetyl hexamethyl tetralin (CAS 21145-77-7)
- Acetyl hexamethyl tetralin (CAS 21145-77-7)
- Acetyl hexamethyl tetralin (CAS 21145-77-7)
- Cetylamine Hydrofluoride (Hexadecyl ammonium fluoride; CAS 3151-59-5)
- Octadecenyl-Ammonium Fluoride (9-Octadecen-1-amine hydrofluoride; CAS 36505-83-6)
- Strontium acetate (Strontium acetate hemihydrate; CAS 543-94-2)
- Nicomethanol Hydrofluoride (3-Pyridinemethanol hydrofluoride; CAS 62756-44-9)
- Benzoic acid Sodium Benzoate (Benzoic acid and its sodium salt; CAS 65-85-0)
- Sodium Fluoride (CAS 7681-49-4)
- Magnesium Fluoride (CAS 7783-40-6)
- Stannous Fluoride (Tin difluoride; CAS 7783-47-3)
- Aluminum Fluoride (Aluminium fluoride; CAS 7784-18-1)
- Potassium Fluoride (CAS 7789-23-3)
- Calcium Monofluorophosphate (Calcium fluorophosphate; CAS 7789-74-4)
- Calcium Fluoride (CAS 7789-75-5)
- Musk ketone (4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone; CAS 81-14-1)
- Musk ketone (4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone; CAS 81-14-1)
- Musk ketone (4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone; CAS 81-14-1)
- Musk xylene (5-tert-Butyl-2,4,6-trinitro-m-xylene; CAS 81-15-2)
- Musk xylene (5-tert-Butyl-2,4,6-trinitro-m-xylene; CAS 81-15-2)
- Musk xylene (5-tert-Butyl-2,4,6-trinitro-m-xylene; CAS 81-15-2)
- 6-Methyl Coumarin (6-Methylcoumarin; CAS 92-48-8)
- 3-(N-Hexadecyl-N-2-hydroxyethylammonio)propylbis(2-hydroxyethyl) ammonium difluoride
- N,N′,N′-Tris(polyoxyethylene)-N-hexadecylpropylenediamine dihydrofluoride
- Applies when
- Applied to: Mouth or Teeth and gums
Depends on: body area
- Effective
Dates run from 11 Jul 2013 to 1 Jan 2027
Each rule has its own date; open a target.
- Source
Example: Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
From the consolidated text: (h) Oral products · (h) 0,004 %
Annex III entry 75 (l7) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- LimitCitral Geranial (CAS 5392-40-5)
Limit 0.65 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (c) 0,65 %. Field of application: (c) Eye products, face make-up and make-up remover.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Eye area
Depends on: body area
- Effective
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-08-01. The row-level date is read from the annex footnote (EU).
- Source
From the consolidated text: (c) Eye products, face make-up and make-up remover · (c) 0,65 %
Annex III entry 70 (l2) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- Limit x 14
14 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.063 % (content basis)
Show targets (14 of 14)
- Citral Geranial (CAS 5392-40-5)
- Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Acetyl Hexamethyl indan (1,1,2,3,3,6-Hexamethylindan-5-yl methyl ketone; CAS 15323-35-0)
- Laureth-9 (Polidocanol; CAS 3055-99-0)
- Iodopropynyl butylcarbamate (3-Iodo-2-propynylbutylcarbamate; CAS 55406-53-6)
- Benzoic acid Sodium Benzoate (Benzoic acid and its sodium salt; CAS 65-85-0)
- Cuminum Cyminum Fruit Oil (Cuminum cyminum oil and extract; CAS 84775-51-9)
- Methyl-N-methylanthranilate (CAS 85-91-6)
- o-Phenylphenol (CAS 90-43-7)
- Tagetes patula flower extract Tagetes patula flower oil (CAS 91722-29-1)
- Tagetes minuta flower extract Tagetes minuta flower oil (CAS 91770-75-1)
- Trialkylamines, trialkanolamines and their salts
- Applies when
- Leave-on product
Depends on: rinse off
- Effective
Dates run from 11 Jul 2013 to 1 Jan 2027
Each rule has its own date; open a target.
- Source
Example: Citral Geranial (CAS 5392-40-5)
From the consolidated text: (i) Leave-on products for the anogenital area (baby wipes and intimate wipes) · (i) 0,063 %
Annex III entry 70 (l8) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- Limit x 17
17 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.2 % (content basis)
Show targets (17 of 17)
- Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Triclocarban (CAS 101-20-2)
- Benzylhemiformal (Methanol, (phenylmethoxy-); CAS 14548-60-8)
- Methylchloroisothiazolinone (and) Methylisothiazolinone (CAS 26172-55-4)
- Methylisothiazolinone (2-Methyl-2H-isothiazol-3-one; CAS 2682-20-4)
- 5-Bromo-5-nitro-1,3-dioxane (CAS 30007-47-7)
- Laureth-9 (Polidocanol; CAS 3055-99-0)
- 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl) 2-pyridon (CAS 50650-76-5)
- Iodopropynyl butylcarbamate (3-Iodo-2-propynylbutylcarbamate; CAS 55406-53-6)
- Phenoxyisopropanol (1-Phenoxypropan-2-ol; CAS 770-35-4)
- Methyl-N-methylanthranilate (CAS 85-91-6)
- o-Phenylphenol (CAS 90-43-7)
- Tagetes patula flower extract Tagetes patula flower oil (CAS 91722-29-1)
- Tagetes minuta flower extract Tagetes minuta flower oil (CAS 91770-75-1)
- Methyleugenol (CAS 93-15-2)
- CI 42520
- Applies when
- Rinse-off product
Depends on: rinse off
- Effective
Dates run from 11 Jul 2013 to 1 Jan 2027
Each rule has its own date; open a target.
- Source
Example: Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
“(a) 0,9 % (b) 0,05 % (c) 0,05 % (d) 0,1 % (e) 0,2 %”
Annex III entry 382 (v4e) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- LimitAluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
Limit 14.62 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (d) 14,62 % (as Al). Field of application: (d) Lip products.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Lips
Depends on: body area
- Effective
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
- Source
From the consolidated text: (d) Lip products · (d) 14,62 % (as Al)
Annex III entry 381 (l3) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- Conformity
Art. 11 removable-replaceable-lmt
Must meet the conditions of LMT batteries and their cells are readily removable and replaceable by an independent professional at any time during the product's lifetime
Consolidated text (not the authentic legal edition), current to 13 Aug 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02023R1542-20260813 from the Publications Office, the latest when read.
- Applies when
- Your role: Manufacturer or Importer
- Contains a battery
- Battery category: LMT battery (e-bike, e-scooter)
Depends on: economic operator role, contains battery, battery category
- Effective
Takes effect 18 Feb 2027
Applies to products placed on the market on or after 18 Feb 2027
Article 11 applies from 18 February 2027 (Art. 96(2)(a)).
- Source
“shall ensure that those batteries, as well as individual battery cells included in the battery pack, are readily removable and replaceable by an independent professional”
Art. 11(5) (excerpt) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EU) 2023/1542(opens in a new tab)
- Conformity
Art. 11 removable-replaceable-portable
Must meet the conditions of Portable batteries incorporated in the product are readily removable and replaceable by the end-user at any time during the product's lifetime (commercially available tools; entire batteries, not cells)
Exemptions (3)
Art. 11(2)(a): appliances designed for splashing water, water streams or immersion and intended to be washable or rinseable may make the battery removable by independent professionals only, where required for safety
“appliances specifically designed to operate primarily in an environment that is regularly subject to splashing water, water streams or water immersion, and that are intended to be washable or rinseable;”
Art. 11(2)(a) (excerpt) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EU) 2023/1542(opens in a new tab) Art. 11(2)(b): professional medical imaging and radiotherapy devices and in vitro diagnostic devices
“professional medical imaging and radiotherapy devices, as defined in Article 2, point (1), of Regulation (EU) 2017/745,”
Art. 11(2)(b) (excerpt) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EU) 2023/1542(opens in a new tab) Art. 11(3): no duty where continuity of power supply is necessary and a permanent connection is required for safety, or for data integrity in data-collecting products
“The obligations laid down in paragraph 1 shall not apply where continuity of power supply is necessary”
Art. 11(3) (excerpt) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EU) 2023/1542(opens in a new tab) Consolidated text (not the authentic legal edition), current to 13 Aug 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02023R1542-20260813 from the Publications Office, the latest when read.
- Applies when
- Contains a battery
- Battery category: Portable battery
- Your role: Manufacturer or Importer
Depends on: contains battery, battery category, economic operator role
- Effective
Takes effect 18 Feb 2027
Applies to products placed on the market on or after 18 Feb 2027
Article 11 applies from 18 February 2027 (Art. 96(2)(a)).
- Source
“products incorporating portable batteries shall ensure that those batteries are readily removable and replaceable by the end-user at any time during the lifetime of the product.”
Art. 11(1) (excerpt) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EU) 2023/1542(opens in a new tab)
- Disclosure
Art. 11 removal-instructions
Disclosure to consumer
Instructions and safety information on use, removal and replacement of the portable battery, permanently available online
Exemptions (3)
Art. 11(2)(a): appliances designed for splashing water, water streams or immersion and intended to be washable or rinseable may make the battery removable by independent professionals only, where required for safety
“appliances specifically designed to operate primarily in an environment that is regularly subject to splashing water, water streams or water immersion, and that are intended to be washable or rinseable;”
Art. 11(2)(a) (excerpt) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EU) 2023/1542(opens in a new tab) Art. 11(2)(b): professional medical imaging and radiotherapy devices and in vitro diagnostic devices
“professional medical imaging and radiotherapy devices, as defined in Article 2, point (1), of Regulation (EU) 2017/745,”
Art. 11(2)(b) (excerpt) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EU) 2023/1542(opens in a new tab) Art. 11(3): no duty where continuity of power supply is necessary and a permanent connection is required for safety, or for data integrity in data-collecting products
“The obligations laid down in paragraph 1 shall not apply where continuity of power supply is necessary”
Art. 11(3) (excerpt) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EU) 2023/1542(opens in a new tab) Consolidated text (not the authentic legal edition), current to 13 Aug 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02023R1542-20260813 from the Publications Office, the latest when read.
- Applies when
- Contains a battery
- Battery category: Portable battery
- Your role: Manufacturer or Importer
Depends on: contains battery, battery category, economic operator role
- Effective
Takes effect 18 Feb 2027
Applies to products placed on the market on or after 18 Feb 2027
Article 11 applies from 18 February 2027 (Art. 96(2)(a)).
- Source
“Those instructions and that safety information shall be made available permanently online, on a publicly available website, in an easily understandable way for end-users.”
Art. 11(1) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EU) 2023/1542(opens in a new tab)
- Conformity
Art. 11 spare-part-availability
Must meet the conditions of Batteries available as spare parts for at least five years after the last unit of the model is placed on the market, at a reasonable and non-discriminatory price
Consolidated text (not the authentic legal edition), current to 13 Aug 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02023R1542-20260813 from the Publications Office, the latest when read.
- Applies when
- Contains a battery
- Battery category: Portable battery or LMT battery (e-bike, e-scooter)
- Your role: Manufacturer or Importer
Depends on: contains battery, battery category, economic operator role
- Effective
Takes effect 18 Feb 2027
Applies to products placed on the market on or after 18 Feb 2027
Article 11 applies from 18 February 2027 (Art. 96(2)(a)).
- Source
“those batteries are available as spare parts of the equipment that they power for a minimum of five years after placing the last unit of the equipment model on the market”
Art. 11(7) (excerpt) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EU) 2023/1542(opens in a new tab)
- Ban
Placing on the market of a cosmetic whose final formulation was animal tested
Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Tested on animals
Depends on: animal testing conducted
- Effective
In force since 11 Mar 2013
Applies to products placed on the market on or after 11 Mar 2013
Art. 18(2): the implementation period for Art. 18(1)(a) was limited to 11 March 2009, and to 11 March 2013 for repeated-dose toxicity, reproductive toxicity and toxicokinetics tests, so the marketing ban covers all tests from 2013-03-11. Art. 40(2) applies the Regulation from 2013-07-11 and does not list Art. 18 among its exceptions.
- Source
“the placing on the market of cosmetic products where the final formulation, in order to meet the requirements of this Regulation, has been the subject of animal testing”
Art. 18(1)(a) (excerpt) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EC) No 1223/2009 (consolidated 2026-05-18)(opens in a new tab)
- Ban
Placing on the market of a cosmetic with animal-tested ingredients or combinations of ingredients
Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Tested on animals
Depends on: animal testing conducted
- Effective
In force since 11 Mar 2013
Applies to products placed on the market on or after 11 Mar 2013
Art. 18(2): the implementation period for Art. 18(1)(b) was limited to 11 March 2009, and to 11 March 2013 for repeated-dose toxicity, reproductive toxicity and toxicokinetics tests, so the marketing ban covers all tests from 2013-03-11. Art. 40(2) applies the Regulation from 2013-07-11 and does not list Art. 18 among its exceptions.
- Source
“the placing on the market of cosmetic products containing ingredients or combinations of ingredients which, in order to meet the requirements of this Regulation, have been the subject of animal testing”
Art. 18(1)(b) (excerpt) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Regulation (EC) No 1223/2009 (consolidated 2026-05-18)(opens in a new tab)
- Ban x 19
19 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Banned
Show targets (19 of 19)
- Acid red 195 (CAS 12220-24-5)
- CI 15800 (Calcium bis[3-hydroxy-4-(phenylazo)-2-naphthoate])
- CI 10020
- CI 16230 (Disodium 7-hydroxy-8-(phenylazo)naphthalene-1,3-disulphonate)
- CI 18050
- CI 21230
- CI 11680 (2-[(4-Methyl-2-nitrophenyl)azo]-3-oxo-N-phenylbutyramide)
- CI 26100
- CI 42045
- CI 11710
- CI 42510
- CI 42735
- CI 44045
- CI 47000
- CI 50420 (Sulfonated nigrosine color)
- CI 59040 (Trisodium 8-hydroxypyrene-1,3,6-trisulphonate)
- CI 12010 (4-[(4-Ethoxyphenyl)azo]naphthol)
- CI 60730
- CI 71105 (Bisbenzimidazo[2,1-b:2',1'-i]benzo[lmn][3,8]phenanthroline-8,17-dione)
- Applies when
- Applied to: Lips or Mouth or Teeth and gums or External genital area
Depends on: body area
- Effective
11 Jul 2013
Each rule has its own date; open a target.
- Source
Example: Acid red 195 (CAS 12220-24-5)
From the consolidated text: Sodium 4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonate · Acid red 195 · 12220-24-5 · — · Red · Not to be used in products applied on mucous membranes
Annex IV entry 153 (restriction) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- BanSalicylic acid (Benzoic acid, 2-hydroxy-; CAS 69-72-7)
Banned
The start date is not stated in the text (date unknown).
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Mouth or Teeth and gums
Depends on: body area
- Effective
In force, start date unknown
No date for this row is stated in the published text (consolidation marker M36; the amending act's application date is not printed). In force no later than 2026-05-18 (the date of the version ClaraDB holds); earlier commencement is not stated in the published text.
- Source
“Not to be used in oral products.”
Annex V entry 3 (l1-restriction) · fetched 2026-10-09European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- Ban x 32
32 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Banned
Show targets (32 of 32)
- Bromothymol blue (CAS 76-59-5)
- Bromocresol green (CAS 76-60-8)
- CI 73900 (5,12-Dihydroquino[2,3-b]acridine-7,14-dione)
- CI 73915 (5,12-Dihydro-2,9-dimethylquino[2,3-b]acridine-7,14-dione)
- CI 74100 (29H,31H-Phthalocyanine)
- CI 74180
- CI 12120 (1-[(4-Methyl-2-nitrophenyl)azo]-2-naphthol)
- CI 12370
- CI 12420
- CI 12480
- CI 12700 (2,4-Dihydro-5-methyl-2-phenyl-4-(phenylazo)-3H-pyrazol-3-one)
- CI 10006
- CI 15620 (Sodium 4-[(2-Hydroxy-1-naphthyl)azo]naphthalenesulphonate)
- CI 18130
- CI 18690
- CI 18736
- CI 18820
- CI 20470
- CI 24790
- CI 40215
- CI 42080
- CI 42100
- CI 42170
- CI 11725
- CI 45100
- CI 45190
- CI 45220
- CI 50325
- CI 51319
- CI 60724 (1-Anilino-4-hydroxyanthraquinone)
- CI 61585
- CI 62045
- Applies when
- Leave-on product
Depends on: rinse off
- Effective
11 Jul 2013
Each rule has its own date; open a target.
- Source
Example: Bromothymol blue (CAS 76-59-5)
From the consolidated text: Phenol, 4,4'-(3H-2,1-benzoxathiol-3-ylidene)bis[2-bromo-3-methyl-6-(1-methylethyl)-, S,S-dioxide · Bromothymol blue · 76-59-5 · 200-971-2 · Blue · Rinse-off products
Annex IV entry 151 (leave-on) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- BanCI 74260 (Polychloro copper phthalocyanine)
Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Eye area
Depends on: body area
- Effective
In force since 11 Jul 2013
Applies to products placed on the market on or after 11 Jul 2013
No row-level date in the consolidated text for this entry; it applies from the Regulation's application date (Art. 40: 11 July 2013). Later amendments (the ▼M markers) are not dated row by row in the text.
- Source
From the consolidated text: Polychloro copper phthalocyanine · 74260 · Green · Not to be used in eye products
Annex IV entry 107 (restriction) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- BanCI 15510
Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Eye area
Depends on: body area
- Effective
In force since 11 Jul 2013
Applies to products placed on the market on or after 11 Jul 2013
No row-level date in the consolidated text for this entry; it applies from the Regulation's application date (Art. 40: 11 July 2013). Later amendments (the ▼M markers) are not dated row by row in the text.
- Source
From the consolidated text: Sodium 4-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments · 15510 · Orange · Not to be used in eye products
Annex IV entry 21 (restriction) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- BanCI 10316
Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Eye area
Depends on: body area
- Effective
In force since 11 Jul 2013
Applies to products placed on the market on or after 11 Jul 2013
No row-level date in the consolidated text for this entry; it applies from the Regulation's application date (Art. 40: 11 July 2013). Later amendments (the ▼M markers) are not dated row by row in the text.
- Source
From the consolidated text: Disodium 5,7-dinitro-8-oxidonaphthalene-2-sulphonate and its insoluble barium, strontium and zirconium lakes, salts and pigments · 10316 · Yellow · Not to be used in eye products
Annex IV entry 3 (restriction) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- BanCI 45405
Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Eye area
Depends on: body area
- Effective
In force since 11 Jul 2013
Applies to products placed on the market on or after 11 Jul 2013
No row-level date in the consolidated text for this entry; it applies from the Regulation's application date (Art. 40: 11 July 2013). Later amendments (the ▼M markers) are not dated row by row in the text.
- Source
From the consolidated text: Dipotassium 3,6-dichloro-2-(2,4,5,7-tetrabromo-6-oxido-3-oxoxanthen-9-yl)benzoate · 45405 · Red · Not to be used in eye products
Annex IV entry 78 (restriction) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- LimitRetinol (CAS 11103-57-4)
Limit 0.05 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE. Field of application: (a) Body lotion (b) other leave-on and rinse-off products. Other: For any cosmetic product containing Retinol, Retinyl Acetate or Retinyl Palmitate the following, labelling is obligatory: ‘Contains Vitamin A. Consider your daily intake before use’..
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Body
Depends on: body area
- Effective
In force since 1 Nov 2025
Applies to products placed on the market on or after 1 Nov 2025
Row footnote: products containing the substance shall not be placed on the Union market from 2025-11-01 and not be made available from 2027-05-01. The row-level date is read from the annex footnote (EU).
- Source
From the consolidated text: 234-328-2/ 200-683-7 · (a) Body lotion (b) other leave-on and rinse-off products · (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE
Annex III entry 376 (v1a) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- LimitAlpha-Arbutin (4-Hydroxyphenyl-alpha-D-glucopyranoside; CAS 84380-01-8)
Limit 0.5 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (a) 2 % (b) 0,5 %. Field of application: (a) Face cream (b) Body lotion. Other: Hydroquinone levels shall remain as low as possible in formulations containing alpha-Arbutin and shall not be higher than the unavoidable trace level..
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Body
Depends on: body area
- Effective
In force since 1 Feb 2025
Applies to products placed on the market on or after 1 Feb 2025
Row footnote: products containing the substance shall not be placed on the Union market from 2025-02-01 and not be made available from 2025-11-01. The row-level date is read from the annex footnote (EU).
- Source
From the consolidated text: 4-Hydroxyphenyl-alpha-D-glucopyranoside (44) · Alpha-Arbutin · 84380-01-8 · 617-561-8 · (a) Face cream (b) Body lotion · (a) 2 % (b) 0,5 %
Annex III entry 377 (v2b) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- LimitThimerosal (Thiomersal; CAS 54-64-8)
Limit 0.007 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: 0,007 % (of Hg) If mixed with other mercurial compounds authorised by this Regulation, the maximum concentration of Hg remains fixed at 0,007 %. Field of application: Eye products.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Eye area
Depends on: body area
- Effective
In force since 11 Jul 2013
Applies to products placed on the market on or after 11 Jul 2013
No row-level date in the consolidated text for this entry; it applies from the Regulation's application date (Art. 40: 11 July 2013). Later amendments (the ▼M markers) are not dated row by row in the text.
- Source
“0,007 % (of Hg) If mixed with other mercurial compounds authorised by this Regulation, the maximum concentration of Hg remains fixed at 0,007 %”
Annex V entry 16 · fetched 2026-10-09European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
Gaps
Markets without rules for this category
We have no rules for this category in these markets. That doesn't mean none apply, so a check here says Not covered, never clear.
ClaraDB gives a verdict only for PFAS state laws for cookware and bakeware, California Proposition 65 consumer-product warning check for BPA, BPS, formaldehyde, styrene, antimony trioxide, vinyl acetate, lead and cadmium, California Proposition 65 warning check for candles and ceramicware (lead, cadmium, formaldehyde, acetaldehyde, benzene, naphthalene, carbon monoxide, benzo[a]pyrene), US packaging EPR producer size thresholds (California, Colorado, Maryland, Minnesota, Oregon, Washington) for a brand-owning manufacturer, US lead in children's products and furniture (lead paint and total lead content), US lead in toys and child care articles (lead paint and total lead content), US lead in children's products (other) and bags (lead paint and total lead content), US phthalates in children's toys and child care articles (DEHP, DBP, BBP, DINP, DIBP, DPENP, DHEXP, DCHP) and US children's product certificate and tracking label for children's tableware (AI-checked, quotes verified word for word). Every other answer shows the laws and quotes found without saying whether they apply. Not checked: Consumer electronics (FCC equipment authorization, 47 CFR Parts 2 and 15, energy rules). What ClaraDB has checked
Show 1 market
- Coverage
- Main sources; no modeled rule is scoped to this category. Not covered: other rules that may apply.
Facts
What we need to know about your product
Some rules depend on details of your product. Until you tell us, a check says Needs answers and asks for what's missing.
Show 37 facts
- Whether the listed substance or group is present
- Markets
- EU, GB, JP, KR, US, US-CA, US-CO, US-CT, US-IL, US-MD, US-ME, US-MN, US-NJ, US-RI, US-VT, US-WA
- Rules
- 7,475
- Number of employees at the seller
- Markets
- US-CA
- Rules
- 972
- Body area
- Markets
- EU, GB, JP, KR
- Rules
- 230
- Rinse off
- Markets
- EU, GB, JP, KR, US-CA
- Rules
- 221
- Economic operator role
- Markets
- EU, GB, KR, US
- Rules
- 90
- Contains battery
- Markets
- EU, GB, US
- Rules
- 39
- Sprayable
- Markets
- EU, GB, KR
- Rules
- 34
- Intended for children under 3
- Markets
- EU, GB, KR
- Rules
- 24
- Battery category
- Markets
- EU, GB
- Rules
- 22
- Otc drug claim
- Markets
- US, US-MN
- Rules
- 20
- Quasi drug or functional claim
- Markets
- JP, KR
- Rules
- 13
- Net content ml
- Markets
- EU, GB, KR
- Rules
- 10
- Battery chemistry
- Markets
- US
- Rules
- 9
- Aerosol dispenser
- Markets
- JP, KR, US
- Rules
- 8
- Professional use
- Markets
- EU, GB, US
- Rules
- 7
- Customised cosmetic
- Markets
- KR
- Rules
- 7
- Rechargeable
- Markets
- US
- Rules
- 6
- Animal testing conducted
- Markets
- EU, GB, KR
- Rules
- 5
- Annual gross revenue usd
- Markets
- US-CO, US-MD, US-MN, US-OR, US-WA
- Rules
- 5
- Contains nanomaterial
- Markets
- EU, GB
- Rules
- 2
- Intended for children under 12
- Markets
- KR
- Rules
- 2
- Single use
- Markets
- KR
- Rules
- 2
- Button or coin cell
- Markets
- US
- Rules
- 2
- Distance sale to other member state
- Markets
- EU
- Rules
- 1
- Imported
- Markets
- KR
- Rules
- 1
- Cattle derived material
- Markets
- US
- Rules
- 1
- Uses sunscreen term
- Markets
- US
- Rules
- 1
- Safety substantiated
- Markets
- US
- Rules
- 1
- Suntanning preparation
- Markets
- US
- Rules
- 1
- Battery removable
- Markets
- US
- Rules
- 1
- Ca gross sales usd
- Markets
- US-CA
- Rules
- 1
- Packaging tons co
- Markets
- US-CO
- Rules
- 1
- Packaging tons md
- Markets
- US-MD
- Rules
- 1
- Packaging tons mn
- Markets
- US-MN
- Rules
- 1
- Packaging tonnes or
- Markets
- US-OR
- Rules
- 1
- Fluorine treated container
- Markets
- US-VT
- Rules
- 1
- Packaging tons wa
- Markets
- US-WA
- Rules
- 1
Changes
Upcoming changes
Rules for this category that start in the next 24 months, or are proposed or on hold.
Show 41 upcoming changes
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to N-Methyl-N-Formylhydrazine, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 8 Dec 2026
Applies to products sold on or after 8 Dec 2026
Listed 2025-12-08 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- N-Methyl-N-Formylhydrazine
- Type of toxicity
- cancer
- Listed by
- the State's Qualified Experts (SQE)
- CAS No.
- 758-17-8
- Date listed
- 8 Dec 2025
Prop 65 list row: N-Methyl-N-Formylhydrazine · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Warning required when exposure exceeds the threshold (no MADL listed for this row)
This product can expose you to Bisphenol S (BPS), which is known to the State of California to cause birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required for a reproductive toxicant where the exposure will produce no observable effect at 1,000 times the level in question (at or below the MADL).
“a warning is not required if the business causing the exposure can demonstrate that the exposure will produce no observable effect, even at 1,000 times the level in question.”
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 8 Dec 2026
Applies to products sold on or after 8 Dec 2026
Listed 2025-12-08 (developmental). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- Bisphenol S (BPS)
- Type of toxicity
- developmental toxicity
- Listed by
- the State's Qualified Experts (SQE)
- CAS No.
- 80-09-1
- Date listed
- 8 Dec 2025
Prop 65 list row: Bisphenol S (BPS) · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Tacrolimus, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- Tacrolimus
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 104987-11-3
- Date listed
- 17 Jul 2026
Prop 65 list row: Tacrolimus · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Hydrochlorothiazide, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- Hydrochlorothiazide
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 58-93-5; 125727-50-6; 8049-49-8
- Date listed
- 17 Jul 2026
Prop 65 list row: Hydrochlorothiazide · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Voriconazole, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- Voriconazole
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 137234-62-9; 188416-29-7; 173967-54-9
- Date listed
- 17 Jul 2026
Prop 65 list row: Voriconazole · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Welding Fumes, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Chemical
- Welding Fumes
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- none given
- Date listed
- 17 Jul 2026
Prop 65 list row: Welding Fumes · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
Every product in the category
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
From the consolidated text: Triphenyl Phosphate (13) · 115-86-6 · 204-112-2
Annex II entry 1767 · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Limit 0.7 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (f) 0,7 %. Field of application: (f) Body lotion.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Body
Depends on: body area
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
From the consolidated text: (f) Body lotion · (f) 0,7 %
Annex III entry 75 (l5) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)11 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.2 % (content basis)
Show targets (11 of 11)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) (Benzoic acid, 2-[4-(diethylamino)-2- hydroxybenzoyl]-, hexyl ester; CAS 302776-68-7)
- Citral Geranial (CAS 5392-40-5)
- Citral Geranial (CAS 5392-40-5)
- Zinc Acetate (CAS 557-34-6)
- Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
Every product in the category
1 Jan 2027
Each rule has its own date; open a target.
Example: Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
From the consolidated text: (g) Face make-up and make-up remover products · (g) 0,2 %
Annex III entry 75 (l6) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)Limit 0.004 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (h) 0,004 %. Field of application: (h) Oral products.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applied to: Mouth or Teeth and gums
Depends on: body area
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
From the consolidated text: (h) Oral products · (h) 0,004 %
Annex III entry 75 (l7) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)- WarningUS-CAN-Methyl-N-Formylhydrazine (CAS 758-17-8)
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to N-Methyl-N-Formylhydrazine, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Appendix A (summary), Exposures that pose no significant risk of cancer (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 8 Dec 2026
Applies to products sold on or after 8 Dec 2026
Listed 2025-12-08 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- N-Methyl-N-Formylhydrazine
- Type of toxicity
- cancer
- Listed by
- the State's Qualified Experts (SQE)
- CAS No.
- 758-17-8
- Date listed
- 8 Dec 2025
Prop 65 list row: N-Methyl-N-Formylhydrazine · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- WarningUS-CABisphenol S (BPS) (CAS 80-09-1)
Warning required when exposure exceeds the threshold (no MADL listed for this row)
This product can expose you to Bisphenol S (BPS), which is known to the State of California to cause birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required for a reproductive toxicant where the exposure will produce no observable effect at 1,000 times the level in question (at or below the MADL).
“a warning is not required if the business causing the exposure can demonstrate that the exposure will produce no observable effect, even at 1,000 times the level in question.”
Appendix A (summary), Exposures that will produce no observable reproductive effect (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 8 Dec 2026
Applies to products sold on or after 8 Dec 2026
Listed 2025-12-08 (developmental). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- Bisphenol S (BPS)
- Type of toxicity
- developmental toxicity
- Listed by
- the State's Qualified Experts (SQE)
- CAS No.
- 80-09-1
- Date listed
- 8 Dec 2025
Prop 65 list row: Bisphenol S (BPS) · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- WarningUS-CATacrolimus (CAS 104987-11-3)
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Tacrolimus, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Appendix A (summary), Exposures that pose no significant risk of cancer (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- Tacrolimus
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 104987-11-3
- Date listed
- 17 Jul 2026
Prop 65 list row: Tacrolimus · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- WarningUS-CAHydrochlorothiazide
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Hydrochlorothiazide, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Appendix A (summary), Exposures that pose no significant risk of cancer (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- Hydrochlorothiazide
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 58-93-5; 125727-50-6; 8049-49-8
- Date listed
- 17 Jul 2026
Prop 65 list row: Hydrochlorothiazide · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- WarningUS-CAVoriconazole
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Voriconazole, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Appendix A (summary), Exposures that pose no significant risk of cancer (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- Voriconazole
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- 137234-62-9; 188416-29-7; 173967-54-9
- Date listed
- 17 Jul 2026
Prop 65 list row: Voriconazole · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- WarningUS-CAWelding Fumes
Warning required when exposure exceeds the threshold (no NSRL listed for this row)
This product can expose you to Welding Fumes, which is known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.
Exemptions (1)
No warning is required where the exposure poses no significant risk of cancer (at or below the NSRL).
a warning is not required if the business causing the exposure can demonstrate that the exposure occurs at a level that poses “no significant risk
Appendix A (summary), Exposures that pose no significant risk of cancer (excerpt) · fetched 2026-10-08California OAG / OEHHA: 27 CCR 27001(opens in a new tab) Official text, current to 31 Jul 2026. OEHHA's own Prop 65 list (XLSX), list dated July 31, 2026.
- Applies when
- Seller has 10 or more employees
- Your business has 10 or more employees and the product knowingly and intentionally exposes someone in California to this chemical
Depends on: number of employees at the seller
- Effective
Takes effect 17 Jul 2027
Applies to products sold on or after 17 Jul 2027
Listed 2026-07-17 (cancer). Grace period: "Proposition 65 warning requirements do not apply until 12 months after the chemical has been listed" (Appendix A); listing date plus 12 months.
- Source
- Chemical
- Welding Fumes
- Type of toxicity
- cancer
- Listed by
- the Labor Code (LC)
- CAS No.
- none given
- Date listed
- 17 Jul 2026
Prop 65 list row: Welding Fumes · fetched 2026-10-08
California OEHHA: 27 CCR 27001(opens in a new tab)
- BanEUTriphenyl Phosphate (CAS 115-86-6)
Banned
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
Every product in the category
- Effective
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
- Source
From the consolidated text: Triphenyl Phosphate (13) · 115-86-6 · 204-112-2
Annex II entry 1767 · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- LimitEUBenzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
Limit 0.7 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (f) 0,7 %. Field of application: (f) Body lotion.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Body
Depends on: body area
- Effective
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
- Source
From the consolidated text: (f) Body lotion · (f) 0,7 %
Annex III entry 75 (l5) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- Limit x 11EU
11 rules from Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI (consolidated)
Limit 0.2 % (content basis)
Show targets (11 of 11)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
- Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) (Benzoic acid, 2-[4-(diethylamino)-2- hydroxybenzoyl]-, hexyl ester; CAS 302776-68-7)
- Citral Geranial (CAS 5392-40-5)
- Citral Geranial (CAS 5392-40-5)
- Zinc Acetate (CAS 557-34-6)
- Acetylated Vetiveria Zizanioides Root Extract (Vetiveria zizanioides, ext., acetylated Oils, vetiver, acetylated; CAS 84082-84-8)
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Aluminium-containing ingredients with the exception of those listed in entries 34, 50, 189, 190 and 192 of Annex III, in entries 117, 118, 119, 121, 131, 150 of Annex IV, in entry 61 in Annex V, and entry 27a of Annex VI.
- Applies when
Every product in the category
- Effective
1 Jan 2027
Each rule has its own date; open a target.
- Source
Example: Benzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
From the consolidated text: (g) Face make-up and make-up remover products · (g) 0,2 %
Annex III entry 75 (l6) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
- LimitEUBenzyl Salicylate (2-hydroxybenzoic acid phenylmethyl ester; CAS 118-58-1)
Limit 0.004 % (content basis)
In the finished (ready for use) cosmetic product. Maximum concentration cell: (h) 0,004 %. Field of application: (h) Oral products.
Consolidated text (not the authentic legal edition), current to 18 May 2026. EUR-Lex consolidated text: a documentation tool without legal effect; the acts published in the Official Journal are authentic. Consolidated version CELEX 02009R1223-20260518 from the Publications Office, the latest when read.
- Applies when
- Applied to: Mouth or Teeth and gums
Depends on: body area
- Effective
Takes effect 1 Jan 2027
Applies to products placed on the market on or after 1 Jan 2027
Row footnote: products containing the substance shall not be placed on the Union market from 2027-01-01 and not be made available from 2028-07-01. The row-level date is read from the annex footnote (EU).
- Source
From the consolidated text: (h) Oral products · (h) 0,004 %
Annex III entry 75 (l7) · fetched 2026-10-09
European Commission / Publications Office (CELLAR): Reg. (EC) 1223/2009 Annexes II-VI(opens in a new tab)
Records
Recalls and alerts
Recalls, safety alerts and Prop 65 notices that name Rinse-off skin cleansers, with a link to the original. A Prop 65 notice is a claim by the sender, not a ruling.
79 records dated 27 Jan 2023 to 10 Apr 2026. Most recent shown.
Show the 8 most recent records
- Prop 65 notices
E.Burnham Retinol Facial Cleansing Lotion with AHA
Cosmetics and personal care
- Substance
- Diethanolamine
- Party
- E BURNHAM LLC, Amazon.com Services LLC
- Category
- Rinse-off skin cleansers
- Prop 65 notices
Lush Kalamazoo Beard and Facial Wash
Cosmetics and personal care
- Substance
- Diethanolamine
- Party
- Lush Retail Limited, Lush USA Inc., Lush Handmade Cosmetics LTD., Cosmetic Warriors Limited, Ulta Salon, Cosmetics & Fragrance, Inc.
- Category
- Rinse-off skin cleansers
- Safety Gate alerts
Cleansing milk - pure & natural
Cosmetics and personal care
- Substance
- None named
- Party
- Not stated
- Category
- Rinse-off skin cleansers
- Prop 65 notices
DearDerm Hyssop Brown Rice & Honey Body Cleanser
Cosmetics and personal care
- Substance
- Diethanolamine
- Party
- Rainbow Beauty Company, Amazon.com Services LLC
- Category
- Rinse-off skin cleansers
- Safety Gate alerts
Body and face wash - MEN + CARE FRESH AWAKE ENERGISING SCENT
Origin as stated: United Kingdom
Cosmetics and personal care
- Substance
- None named
- Party
- Not stated
- Category
- Rinse-off skin cleansers
- Safety Gate alerts
Body wash - CARE BODY AND FACE WASH
Origin as stated: United Kingdom
Cosmetics and personal care
- Substance
- None named
- Party
- Not stated
- Category
- Rinse-off skin cleansersBath and shower products
- Safety Gate alerts
Cleansing milk - Revitalfit
Origin as stated: France
Cosmetics and personal care
- Substance
- None named
- Party
- Not stated
- Category
- Rinse-off skin cleansers
- Safety Gate alerts
Make-up remover - Lait démaquillant douceur
Origin as stated: France
Cosmetics and personal care
- Substance
- None named
- Party
- Not stated
- Category
- Rinse-off skin cleansers
See also
Related categories
- Skin care
Face and body skin products, sun protection and exfoliants.
- Leave-on skin care
Creams, lotions, serums, oils and balms for face and body that stay on the skin (EU: leave-on product).
- Sun protection
Sunscreens and sun-protection products. US: OTC drug (monograph M020) and a cosmetic only when the sun claim is secondary; EU/UK: cosmetic with Annex VI UV filters; KR/JP: functional cosmetic or quasi-drug.
- Exfoliating acids and peels
AHA, BHA and similar chemical peels and exfoliants, general and professional use (EU Annex III splits limits by general and professional use).
Alerts
Get an email when these rules change.
Check a product free, no account needed. Save it, and you see when a rule that affects it changes, and Team emails you the day it does.